Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

How to integrate the Nu.Q® Vet Cancer Test into your hospital/clinic workflow

Key Takeaway: The article offers a comprehensive guide for integrating the Nu.Q® Vet Cancer Test into veterinary workflows. It covers essential aspects such as PIMS integration, staff training, and client education. The resource aims to enhance communication among veterinary staff and promote early cancer screening during wellness visits.
Price reaction · baseline $13.94 (2025-07-16T14:54:00.000Z) · hit during market hours · 1 other VNRX headline(s) in the window, move may be shared
day 0 close · peak
+0.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • Provides clear step-by-step integration instructions.
  • Equips staff with tools to promote early cancer screening.
  • Includes resources for both client education and in-clinic communication.

Full Press Release Details

This practical guide outlines step-by-step instructions for seamlessly integrating the Nu.Q ® Vet Cancer Test into your veterinary clinic or hospital workflow. It includes recommendations on PIMS integration, staff training, client education, and in-clinic communication strategies. With talking points for receptionists, technicians, and vets, this resource equips your team to confidently promote early cancer screening for dogs during routine wellness visits.
Download this version if you use reference laboratories to submit your Nu.Q® Vet samples.
Download this version if you use the Element i+™ to submit your Nu.Q® Vet samples.

Related Articles

• Press Releases Volition Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats. The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 million contractual milestone payment
• Press Releases Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems

Volition Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats. The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 million contractual milestone payment

Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What is the Nu.Q® Vet Cancer Test?

The Nu.Q® Vet Cancer Test is a diagnostic tool for early cancer screening in dogs.

How can clinics integrate the Nu.Q® Vet Cancer Test?

Clinics can integrate the test by following step-by-step instructions provided in the guide.

What resources are available for staff training?

The guide includes talking points and training materials for receptionists, technicians, and vets.

Why is early cancer screening important?

Early cancer screening can lead to better outcomes for dogs by detecting issues sooner.

Last updated: Jul 16, 2025